Conversely, patients requiring insulin preoperatively may have partially preserved β‐cell function but significant insulin resistance; after surgery, the rapid improvement in insulin sensitivity, combined with enhanced GLP‐1–mediated insulin secretion, may lead to relative insulin excess and hypoglycemia if exogenous insulin dosing is not promptly adjusted [42, 44]. The gene discussed is GCG; the disease is Hypoglycemia.